A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Gavin P Dunn
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
414 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pan American Center for Oncology Trials Llc
San Juan, Puerto Rico
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mercy Cancer Center - Carmichael
Carmichael, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- Mercy Cancer Center - Elk Grove
Elk Grove, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Mercy Cancer Center - Rocklin
Rocklin, California, United States
- Mercy Cancer Center - Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
- Mission Hope Medical Oncology - Santa Maria
Santa Maria, California, United States
- Torrance Memorial Medical Center
Torrance, California, United States
- Torrance Memorial Physician Network - Cancer Care
Torrance, California, United States
- Woodland Memorial Hospital
Woodland, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
- Adventhealth Porter
Denver, Colorado, United States
- Commonspirit Cancer Center Mercy
Durango, Colorado, United States
- Mercy Medical Center
Durango, Colorado, United States
- Commonspirit Saint Anthony Hospital Cancer Center
Lakewood, Colorado, United States
- Adventhealth Littleton
Littleton, Colorado, United States
- Longmont United Hospital
Longmont, Colorado, United States
- Rocky Mountain Cancer Centers-Longmont
Longmont, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Dec 2020
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 4 Aug 2026
- Registered enrollment
- 37
- Registry id
- NCT04145115
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.